Roxro Pharma
Menlo Park
About Roxro Pharma
ROXRO PHARMA, develops drugs for pain treatment. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; and ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine. ROXRO PHARMA, Inc. was founded in 1999 and is based in Menlo Park, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $68.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2007)
- Website: roxropharma.com
- Phone: +1 650-322-4554
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/roxro-pharma-3125443 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.